Femoroacetabular impingement syndrome Musculoskeletal Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients referred to Cambridge Young Adult Hip service (aged 16-50 years), undergoing hip arthroscopy for Femoroacetabular Impingement Syndrome.
Exclusion criteria
Exclusion criteria: 1. Previous hip disease such as Perthe’s, Slipped upper femoral epiphysis or avascular necrosis 2. Participants who are unable to give full written consent. 3. Pre-existing neuromuscular conditions like Motor neuron disease or Multiple sclerosis. 4. History of any previous hip surgery 5. History of any previous hip arthroscopies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The iHOT-12 is a patient-reported outcome of Quality of Life (QoL) and will be the planned primary outcome measure for this study. This will be measured at baseline, Pre-op (after prehabilitation), 6 weeks, 6 months and 12 months post-op. Added 22/08/2023: Study follow-up points will be +/- 4 weeks to accommodate flexibility in clinic appointments within the NHS: Upon further consideration of the current situation and waiting times within the NHS, having a rigid follow-up point would not be feasible. Therefore, the follow-up points are kept flexible, but within a reasonable duration, so this does not affect the quality of the study. Patient-reported outcome measures will be completed digitally via online surveys at baseline and all other follow-up points (at pre-op, 6 weeks,6 months and 12 months post-op) using REDCap. A link to the online outcome measures survey with instructions will be emailed to participants for completion at the above follow-up points. If participants forget to complete the outcome questionnaire on the required day, a reminder to complete it will be sent on two more occasions after the deadline to facilitate compliance. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Hip muscle strength using a handheld dynamometer will be measured at baseline, Pre-op (after prehabilitation), 6 weeks and 6 months post-op. 2. The Star excursion balance test is a reliable measure to assess dynamic postural control and proprioception and will be measured at baseline, Pre-op (after prehabilitation), 6 weeks and 6 months post-op. 3. Pain will be measured using Brief Pain Inventory-short form (BPI) and will be measured at baseline, Pre-op (after prehabilitation), 6 weeks, 6 months and 12 months post-op. 4. Anxiety and depression will be measured using Hospital Anxiety and Depression Scale (HADS) at baseline, Pre-op (after prehabilitation), 6 weeks, 6 months and 12 months post-op. 5. Patient’s Global Impression of Change (PGIC) will be used to gather a patient’s perception of change after intervention and will be measured at baseline, Pre-op (after prehabilitation), 6 weeks, 6 months and 12 months post-op. Added 22/08/2023: Study follow-up points will be +/- 4 weeks to accommodate flexibility in clinic appointments within the NHS: Upon further consideration of the current situation and waiting times within the NHS, having a rigid follow-up point would not be feasible. Therefore, the follow-up points are kept flexible, but within a reasonable duration, so this does not affect the quality of the study. Patient-reported outcome measures will be completed digitally via online surveys at baseline and all other follow-up points (at pre-op, 6 weeks,6 months and 12 months post-op) using REDCap. A link to the online outcome measures survey with instructions will be emailed to participants for completion at the above follow-up points. If participants forget to complete the outcome questionnaire on the required day, a reminder to complete it will be sent on two more occasions after the deadline to facilitate compliance. | — |
Countries
England, United Kingdom